Mefoglip Tablet

About Mefoglip 2.5 mg + 500 mg Tablet

Mefoglip is a combination tablet for type 2 diabetes that pairs glipizide, which prompts the pancreas to release insulin, with metformin, which helps the body use glucose more effectively.

There are 6 brands of Glipizide + Metformin Hydrochloride listed in Bangladesh. 2 of them have a lower unit price than Mefoglip. The lowest listed price is Mefoglip 2.5 mg + 250 mg Tablet at ৳ 1.9 per unit.

What is Mefoglip 2.5 mg + 500 mg Tablet?

Mefoglip 2.5 mg + 500 mg tablet is a combination oral medicine for type 2 diabetes. It contains glipizide, a sulfonylurea that increases insulin release from the pancreas, and metformin, a biguanide that lowers glucose production in the liver and improves the body's response to insulin. Together they help improve blood sugar control when diet and exercise alone are not enough. The tablet is made by Incepta Pharmaceuticals Ltd. and is available in a pack of 3 x 10 tablets. It is used under a doctor's supervision, and the dose is set by the doctor.

Uses of Mefoglip

Mefoglip is used to improve blood sugar control in adults with type 2 diabetes when diet and exercise alone do not work well enough. It can be started as initial therapy or used as second-line therapy when other treatments have not achieved satisfactory control. It is not for type 1 diabetes or diabetic ketoacidosis. Your doctor will decide if this medicine is suitable for you.

How to use Mefoglip

Take Mefoglip exactly as your doctor prescribes. The tablet is usually taken with meals, but the doctor will decide the dose and how often you take it. Swallow the tablet with water. Do not change the dose or stop taking it without talking to your doctor. If you miss a dose, ask your doctor or pharmacist what to do. Follow your diet and exercise plan as advised.

Side effects of Mefoglip

Like all medicines, Mefoglip can cause side effects. The most common include low blood sugar (hypoglycemia), diarrhea, nausea or vomiting, abdominal pain, headache, and muscle or joint pain. If you experience any side effects, contact your doctor or pharmacist. They can advise you on what to do. Do not stop taking the medicine without medical advice.

Safety and precautions

Mefoglip is not suitable for everyone. It should not be used if you have kidney problems, diabetic coma or ketoacidosis, chronic kidney disease, heart failure, trauma, dehydration, alcohol dependence, or if you are pregnant or breastfeeding. Tell your doctor about all your medical conditions and medicines before starting this tablet. Older adults may need careful dose adjustment. Your doctor will check your kidney function and may stop the medicine before surgery. Always ask your doctor or pharmacist if you have any questions about safety.

Frequently asked questions

What is Mefoglip used for and what kind of medicine is it?

Mefoglip is a combination oral hypoglycemic tablet used to treat type 2 diabetes. It contains glipizide and metformin, which work together to help control blood sugar when diet and exercise alone are not enough. It is not for type 1 diabetes. Your doctor will decide if it is right for you.

How should I store Mefoglip?

Store Mefoglip below 25°C in a cool and dry place. Keep it out of reach of children. Do not use it after the expiry date printed on the pack. If you have any questions about storage, ask your pharmacist.

What does the generic name mean?

The generic name of Mefoglip is Glipizide + Metformin Hydrochloride. Glipizide is a sulfonylurea that helps the pancreas release more insulin. Metformin is a biguanide that lowers glucose production in the liver and improves insulin sensitivity. Together they help control blood sugar in type 2 diabetes.

What is the price of Mefoglip?

The listed price is ৳ 2.8. For the most up-to-date price, please check the website or ask your pharmacist. The doctor or pharmacist can also advise on the dose and course.

Indications

Glipizide & Metformin is indicated as initial therapy, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes whose hyperglycemia cannot be satisfactorily managed with diet and exercise alone and as second-line therapy when diet, exercise, and initial treatment ... Read moreGlipizide & Metformin is indicated as initial therapy, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes whose hyperglycemia cannot be satisfactorily managed with diet and exercise alone and as second-line therapy when diet, exercise, and initial treatment with a Sulfonylurea or Metformin do not result in adequate glycemic control in patients with type 2 diabetes

Pharmacology

Metformin is a biguanide antihyperglycemic agent, which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Its pharmacological mechanisms of action are different from other classes of oral antihyperglycemic agents. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Unlike sulfonylurea, metformin does not produce hypoglycemia in either patient with type 2 diabetes or normal subjects and does not cause hyperinsulinemia.

Glipizide is a sulfonylurea which appears to lower blood glucose by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. Extrapancreatic effects may play a part in the mechanism of action of oral sulfonylurea hypoglycemic drugs.

Dosage & Administration

Glipizide & Metformin should be given once or twice daily with meals and should be initiated at a low dose, with gradual dose escalation.

Glipizide & Metformin as Initial Therapy: The recommended starting dose is 250 mg/2.5 mg once a day with meal.

Glipizide & Metformin as Second-Line Therapy: The recommended starting dose is 500 mg/2.5 mg or 500 mg/5 mg twice daily with the morning and evening meals. The maximum recommended daily dose is 2000 mg Metformin/20 mg Glipizide.

Interaction

Cimetidine reduces the renal clearance of Metformin. Alcohol potentiates the antihyperglycemic & hyperlactataemic effect of Metformin. It may enhance the effects of anti-coagulants. Such patients receiving the two drugs may need adjustment of the anti-coagulant dosage. Nifedipine appears to enhance the absorption of Metformin but Metformin has minimal effects on Nifedipine. The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles, and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.

Contraindications

Hypersensitivity to the drug, renal impairment, diabetic coma and ketoacidosis, chronic renal diseases, congestive heart failure, trauma, dehydration, alcohol dependence, pregnancy, breast-feeding etc.

Side Effects

The most common side effects of Glipizide & Metformin are hypoglycemia,
diarrhea, nausea/vomiting, abdominal pain, headache, musculoskeletal pain etc.

Pregnancy & Lactation

Contraindicated during Pregnancy & Lactation

Precautions & Warnings

Metformin is known to be substantially excreted by the kidney, and the risk of Metformin accumulation and lactic acidosis is increased with the degree of impairment of renal function. Thus, patients with serum creatinine levels above the upper limit of normal should not receive Metformin. In patients with advanced age, Metformin should be carefully titrated to establish minimum dose for adequate glycemic control, because aging is associated with reduced renal function. Metformin therapy should be temporarily suspended for any surgical procedure and should not be restarted until the patient’s oral intake has resumed and renal function has been evaluated as normal. During concomitant therapy with sulfonylurea, blood glucose should be monitored. Metformin & insulin therapy should be carried out in hospital until the correct ratio of the two drugs has been established. The metabolism and excretion of Glipizide may be slowed in patients with impaired renal and/or hepatic function. If hypoglycemia should occur in such patients, it may be prolonged and appropriate management should be instituted.

Storage Conditions

Store below 25ºC in a cool and dry place.

Alternative brands of Glipizide + Metformin Hydrochloride

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.